Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
152.3 EUR | +0.57% | -2.22% | +0.64% |
Composition of VanEck Biotech ETF - USD
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| ||
---|---|---|---|---|---|---|
307.4 USD | +0.51% | +0.52% | +6.74% | 19.50% | ||
470.2 USD | +3.26% | +2.90% | +15.55% | 11.25% | ||
63.43 USD | -1.31% | -3.43% | -21.70% | 9.94% | ||
989.5 USD | +0.95% | +0.45% | +12.66% | 8.97% | ||
147.8 USD | +3.70% | -11.28% | +48.64% | 5.32% | ||
216.5 USD | -1.20% | -5.72% | -6.44% | 4.71% | ||
229.8 USD | +2.16% | +5.50% | -11.20% | 4.58% | ||
323.5 USD | -0.41% | +0.86% | +14.28% | 4.00% | ||
103.4 USD | -0.87% | -2.92% | -25.76% | 3.79% | ||
146.2 USD | -1.75% | -4.24% | -18.92% | 2.58% | ||
76.41 USD | +1.79% | +1.18% | -20.75% | 2.48% | ||
150.4 USD | +1.36% | +1.82% | -21.40% | 2.17% | ||
124.2 USD | -4.34% | +0.62% | +28.83% | 2.04% | ||
207.9 USD | -0.24% | -4.27% | -12.04% | 1.97% | ||
102.9 USD | +2.26% | +6.11% | -2.53% | 1.97% | ||
77.9 USD | +0.92% | -3.58% | +0.96% | 1.90% | ||
44.82 USD | -1.39% | -10.07% | -39.42% | 1.82% | ||
44 USD | +1.71% | +0.62% | -1.73% | 1.75% | ||
150.4 USD | +0.85% | -4.94% | -16.38% | 1.69% | ||
58.8 USD | +1.75% | +2.60% | -6.35% | 1.64% | ||
108.3 USD | +1.67% | -1.10% | +72.91% | 1.36% | ||
57.15 USD | +6.35% | +3.46% | -8.71% | 0.89% | ||
Description
US92189F7261 | |
---|---|
Total Expense Ratio | 0.35% |
Asset Class | |
Sector | |
Size | |
Currency | |
Provider | |
Underlying | MVIS US Listed Biotech 25 Net Total Return Index - USD |
Features and characteristics
Jurisdiction | |
Fund Structure | |
Replication Method | |
Replication Model | |
Date of creation |
18/12/2011
|
Dividend Policy | |
Geographical Focus |
AuM evolution ( 29/04/2024 )
AuM (EUR) | 387 M€ |
---|---|
AuM 1M | 417 M€ |
AuM 3 months | 432 M€ |
AuM 6 months | 396 M€ |
AuM 12 months | 457 M€ |
- Stock Market
- ETF
- VEFU ETF
- Components VanEck Biotech ETF - USD